363 related articles for article (PubMed ID: 9558335)
1. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
2. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
Wu Y; Craig TA; Lutz WH; Kumar R
Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dehydroxyvitamin D3 synergism toward transforming growth factor-beta1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor.
Takeshita A; Imai K; Kato S; Kitano S; Hanazawa S
J Biol Chem; 1998 Jun; 273(24):14738-44. PubMed ID: 9614072
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
8. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
Uchida M; Ozono K; Pike JW
J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
[TBL] [Abstract][Full Text] [Related]
9. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
11. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
Jurutka PW; Terpening CM; Haussler MR
Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128
[TBL] [Abstract][Full Text] [Related]
12. 1Alpha25(OH)2D3 interferes with retinoic acid-induced inhibition of c-fos gene expression for AP-1 formation in osteoblastic cells.
Takeshita A; Yasuda H; Ishida M; Ochiai K
J Oral Sci; 2002 Mar; 44(1):27-34. PubMed ID: 12058867
[TBL] [Abstract][Full Text] [Related]
13. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
Stephanou A; Ross R; Handwerger S
Endocrinology; 1994 Dec; 135(6):2651-6. PubMed ID: 7988455
[TBL] [Abstract][Full Text] [Related]
15. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
16. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.
Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475
[TBL] [Abstract][Full Text] [Related]
17. A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun.
Towers TL; Staeva TP; Freedman LP
Mol Cell Biol; 1999 Jun; 19(6):4191-9. PubMed ID: 10330159
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells.
Veenstra TD; Windebank AJ; Kumar R
Biochem Biophys Res Commun; 1997 Jun; 235(1):15-8. PubMed ID: 9196027
[TBL] [Abstract][Full Text] [Related]
19. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter.
Hines ER; Kolek OI; Jones MD; Serey SH; Sirjani NB; Kiela PR; Jurutka PW; Haussler MR; Collins JF; Ghishan FK
J Biol Chem; 2004 Nov; 279(45):46406-14. PubMed ID: 15337762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
